Approval · Notice of Compliance 2297 · 2001
KYTRIL: Notice of Compliance 2297
Issued February 13, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2297
- Date
- February 13, 2001
- Company
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antiemetic
Products in this notice
Medicinal ingredients
- GRANISETRON HCL 1 MG per ML
- GRANISETRON HCL 1 MG per TAB
- GRANISETRON HCL 2 MG per TAB